2026-06-14T02:28:49Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/156492024-09-27T09:30:12Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Rajpal, Saurabh author Kahwash, Rami author Tong, Matthew S author Paschke, Kelly author Satoskar, Anjali A author Foreman, Beth author Allen, Larry A author Bhave, Nicole M author Gluckman, Ty J author Fuster, Valentin author 2022-05-31 A 60-year-old woman with a past medical history of asthma presented with fulminant myocarditis 9 days after testing positive for SARS-CoV-2 and 16 days after developing symptoms consistent with COVID-19. Her hospital course was complicated by the need for veno-arterial extracorporeal membrane oxygenation, ventricular arrhythmias, and pseudomonas bacteremia. She ultimately recovered and was discharged to home with normal left ventricular systolic function. Thereafter, she developed symptomatic ventricular tachycardia, for which she received an implantable cardioverter-defibrillator and antiarrhythmic drug therapy. J Am Coll Cardiol. 2022 May 31;79(21):2144-2152 10.1016/j.jacc.2022.03.346 1558-3597 Journal of the American College of Cardiology 35364210 http://hdl.handle.net/20.500.12105/15649 Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways.